Matrisome Bio, co-founded by KI alum Noor Jailkhani, Richard Hynes and Sangeeta Bhatia, has been named a 2026 Prix Galien USA nominee for Best Startup. The company is developing therapies that target the extracellular matrix of tumors and metastases using a platform technology initially developed by Jailkhani as a Mazumdar-Shaw International Oncology Fellow. Winners will be announced October 29 in New York City.